Glycyrrhizic acid exhibits strong anticancer activity in colorectal cancer cells via SIRT3 inhibition

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7-33.
   PubMed Web of Science ®Google Scholar
• Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 global cancer statistics? Cancer Commun. 2019;39:1–12.
   Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen Z, Li J. The current status of treatment for colorectal cancer in China: a systematic review. Medicine. 2017;96:1-6.
   Google Scholar
• Huang HY, Shi JF, Guo LW, et al. Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital‐based, multicenter, cross‐sectional survey. Cancer Commun. 2017;36:1–15.
   Google Scholar
• Zhu L, Wei M, Yang N, et al. Glycyrrhizic acid alleviates the meconium-induced acute lung injury in neonatal rats by inhibiting oxidative stress through mediating the Keap1/Nrf2/HO-1 signal pathway. Bioengineered. 2021;12:2616–2626.
   PubMed Web of Science ®Google Scholar
• Zyca B, Yzl A, Jml A, et al. Glycyrrhizic acid as an adjunctive treatment for depression through anti-inflammation: a randomized placebo-controlled clinical trial. J Affect Disord. 2020;265:247–254.
   PubMed Web of Science ®Google Scholar
• Lin S-C, Chu P-Y, Liao W-T, et al. Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway. Oncol Rep. 2018;39:703–710.
   PubMed Web of Science ®Google Scholar
• Sahin F, Oznurhan F. Antibacterial efficacy and remineralization capacity of glycyrrhizic acid added casein phosphopeptide‐amorphous calcium phosphate. Microsc Res Tech. 2020;83:744–754.
   PubMed Web of Science ®Google Scholar
• He SQ, Gao M, Fu YF, et al. Glycyrrhizic acid inhibits leukemia cell growth and migration via blocking AKT/mTOR/STAT3 signaling. Int J Clin Exp Pathol. 2015;8:5175.
   PubMed Web of Science ®Google Scholar
• Tang ZH, Li T, Chang LL, et al. Glycyrrhetinic Acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells. J Agric Food Chem. 2014;62:11910–11916.
   PubMed Web of Science ®Google Scholar
• Zhu J, Chen M, Chen N, et al. Glycyrrhetinic acid induces G1-phase cell cycle arrest in human non-small cell lung cancer cells through endoplasmic reticulum stress pathway. Int J Oncol. 2015;46:981–988.
   PubMed Web of Science ®Google Scholar
• Wang XF, Zhou QM, Lu YY, et al. Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis. Expert Opin Ther Targets. 2015;19:577.
   PubMed Web of Science ®Google Scholar
• Khan R, Rehman MU, Khan AQ, et al. Glycyrrhizic acid suppresses 1, 2‐dimethylhydrazine‐induced colon tumorigenesis in Wistar rats: alleviation of inflammatory, proliferation, angiogenic, and apoptotic markers. Environ Toxicol. 2018;33:1272–1283.
   PubMed Web of Science ®Google Scholar
• Rehan K, Quaiyoom KA, Abdul L, et al. Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, Inflammation, Angiogenesis and apoptosis in the colon of wistar rats. Plos One. 2013;8:e56020.
   PubMed Web of Science ®Google Scholar
• Wang S, Yong S, Qiu R, et al. 18β-glycyrrhetinic acid exhibits potent antitumor effects against colorectal cancer via inhibition of cell proliferation and migration. Int J Oncol. 2017;51:615.
   PubMed Web of Science ®Google Scholar
• Han L, Long Q, Li S, et al. Senescent stromal cells promote cancer resistance through SIRT1 loss-potentiated overproduction of small extracellular vesicles. Cancer Res. 2020;80(canres.0506.2020):3383–3398.
   Google Scholar
• Xing J, Li J, Fu L, et al. SIRT4 enhances the sensitivity of ER‐positive breast cancer to tamoxifen by inhibiting the IL‐6/STAT3 signal pathway. Cancer Med. 2019;8:7086–7097.
   PubMed Web of Science ®Google Scholar
• Vitiello M, Zullo A, Servillo L, et al. Multiple pathways of SIRT6 at the crossroads in the control of longevity, cancer, and cardiovascular diseases. Ageing Res Rev. 2017;35:301–311.
   PubMed Web of Science ®Google Scholar
• Liu C, Huang Z, Hong J, et al. The Sirtuin 3 expression profile is associated with pathological and clinical outcomes in colon cancer patients. Biomed Res Int. 2014;2014:871263.
   PubMed Web of Science ®Google Scholar
• Chen Y, Fu LL, Wen X, et al. Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. Cell Death Dis. 2014;5:e1047.
   PubMed Web of Science ®Google Scholar
• Torrens‐Mas M, Hernández‐López R, Oliver J, et al. 3 silencing improves oxaliplatin efficacy through acetylation of MnSOD in colon cancer. J Cell Physiol. 2018;233:6067–6076.
   PubMed Web of Science ®Google Scholar
• Lu Q, Liu Z, He W, et al. Protective effects of ulinastatin on rats with acute lung injury induced by lipopolysaccharide. Bioengineered. 2021. DOI:10.1080/21655979.2021.1987083
   Google Scholar
• Zhang H, Fang Z, Guo Y, et al. Long noncoding RNA SNHG10 promotes colorectal cancer cells malignant progression by targeting miR-3690. Bioengineered. 2021;12:6010–6020.
   PubMed Web of Science ®Google Scholar
• SIRT3. Oncogene and tumor suppressor in cancer. Cancers (Basel). 2017;9:90.
   PubMed Web of Science ®Google Scholar
• Kim HS, Patel K, Muldoon-Jacobs K, et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 2010;17:41–52.
   PubMed Web of Science ®Google Scholar
• Li R, Quan Y, Xia W. SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt/β-catenin pathway. Experimental Cell Research. 2018;364:143-151.
   Web of Science ®Google Scholar
• Dds T, Kamarajan P, Joo MN, et al. Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer. 2011;117:1670-1678.
   PubMedGoogle Scholar
• Tong S, Fei W, Emily S, et al. SIRT3, a mitochondrial sirtuin deacetylase, Regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem. 2005;280:13560–13567.
   PubMed Web of Science ®Google Scholar
• Li H, Feng Z, Wu W, et al. SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non-small cell lung cancer cells through deacetylation of NMNAT2. Int J Oncol. 2013;43:1420–1430.
   PubMed Web of Science ®Google Scholar
• Müller W, Noguchi T, Wirtz H, et al. Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21 WAF1/CIP1 in gastric cancer. J Pathol. 2015;189:186–193.
   Google Scholar
• Fadaka AO, Sibuyi N, Bakare OO, et al. Expression of cyclin-dependent kinases and their clinical significance with immune infiltrates could predict prognosis in colorectal cancer. Biotechnology Reports. 2021;29:1-15.
   Google Scholar
• Riess C, Irmscher N, Salewski I, et al. Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology? Cancer and Metastasis review. 2021;40:153-171.
   Web of Science ®Google Scholar
• Nurse P. Cyclin dependent kinases and cell cycle control (Nobel Lecture). Chembiochem. 2015;3:596–603.
   Google Scholar
• Grison A, Atanasoski S. Cyclins, Cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in the mouse nervous system. Mol Neurobiol. 2020;57:3206–3218.
   PubMed Web of Science ®Google Scholar
• Yao D, Wang P, Zhang J, et al. Deconvoluting the relationships between autophagy and metastasis for potential cancer therapy. Apoptosis. 2016;21:683–698.
   PubMed Web of Science ®Google Scholar
• Radisky DC. Epithelial-mesenchymal transition. Cancer Res. 2008;68:9574.
   PubMed Web of Science ®Google Scholar
• Giralt A, Villarroya F. SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochem J. 2012;444:1–10.
   PubMed Web of Science ®Google Scholar
• Jablonski RP, Kim SJ, Cheresh P, et al. SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis. FASEB J. 2017;31:2520-2532.
   PubMed Web of Science ®Google Scholar
• Mei Y, Chunsong Y, Yuhua P. Effects of downregulation of SIRT3 expression on proliferation and apoptosis in esophageal squamous cell carcinoma EC9706 cells and its molecular mechanisms. Biomed Mater Eng. 2014;24:3883–3890.
   PubMed Web of Science ®Google Scholar
• Qiao A, Wang K, Yuan Y, et al. Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia. Oncotarget. 2016:7:43390-43400.
   PubMedGoogle Scholar
• Zw A, Ying LB, Ying WC, et al. Pyrroloquinoline quinine protects HK-2cells against high glucose-induced oxidative stress and apoptosis through Sirt3 and PI3K/Akt/FoxO3a signaling pathway. Biochem Biophys Res Commun. 2019;508:398–404.
   PubMed Web of Science ®Google Scholar
• Wong WL, Puthalakath H. Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway. Iubmb Life. 2010;60:390–397.
   Web of Science ®Google Scholar